Literature DB >> 11830291

Cellular localization of orexin receptors in human adrenal gland, adrenocortical adenomas and pheochromocytomas.

Montserrat Blanco1, Tomás García-Caballero, Máximo Fraga, Rosalía Gallego, Juan Cuevas, Jerónimo Forteza, Andrés Beiras, Carlos Diéguez.   

Abstract

Orexin-A and -B are hypothalamic peptides derived from a precursor called prepro-orexin and related with the regulation of the energy balance and arousal. They act on G protein receptors named orexin receptor 1 (OX1R) and orexin receptor 2 (OX2R). In the present study, we used immunohistochemical techniques to detect the distribution of OXR in normal human adrenal gland and adrenal tumours (adrenocortical adenomas and pheochromocytomas). OX1R was expressed in the cortex of the normal human adrenal gland (glomerulosa, fasciculata and reticular zones) and OX2R was located in the medulla (epinephrine and norepinephrine cells). By the double immunofluorescence techniques, we demonstrated that virtually all medullar cells (epinephrine and norepinephrine cells) expressed OX2R. As was expected, according to the results obtained in normal tissues, cortical tumours (adrenocortical adenomas) were positive for OX1R but not for OX2R and conversely, medullar tumours (pheochromocytomas) expressed only OX2R.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11830291     DOI: 10.1016/s0167-0115(01)00359-7

Source DB:  PubMed          Journal:  Regul Pept        ISSN: 0167-0115


  10 in total

Review 1.  Hypocretins and the neurobiology of sleep-wake mechanisms.

Authors:  Luis de Lecea
Journal:  Prog Brain Res       Date:  2012       Impact factor: 2.453

Review 2.  Stress and arousal: the corticotrophin-releasing factor/hypocretin circuitry.

Authors:  Raphaëlle Winsky-Sommerer; Benjamin Boutrel; Luis de Lecea
Journal:  Mol Neurobiol       Date:  2005-12       Impact factor: 5.590

3.  Expression of orexin A and its receptor 1 in the human prostate.

Authors:  Salvatore Valiante; Giovanna Liguori; Simona Tafuri; Roberto Campese; Roberto Monaco; Salvatore Paino; Vincenza Laforgia; Norma Staiano; Alfredo Vittoria
Journal:  J Anat       Date:  2013-02-21       Impact factor: 2.610

4.  Merkel cells, a new localization of prepro-orexin and orexin receptors.

Authors:  Andrés Beiras-Fernández; Rosalía Gallego; Montserrat Blanco; Tomás García-Caballero; Carlos Diéguez; Andrés Beiras
Journal:  J Anat       Date:  2004-02       Impact factor: 2.610

5.  The selective orexin receptor 1 antagonist ACT-335827 in a rat model of diet-induced obesity associated with metabolic syndrome.

Authors:  Michel A Steiner; Carla Sciarretta; Anne Pasquali; Francois Jenck
Journal:  Front Pharmacol       Date:  2013-12-30       Impact factor: 5.810

6.  Attenuated cold defense responses in orexin neuron-ablated rats.

Authors:  Mazher Mohammed; Masashi Yanagisawa; William Blessing; Youichirou Ootsuka
Journal:  Temperature (Austin)       Date:  2016-04-29

7.  Antistress effects of Kampo medicine "Yokukansan" via regulation of orexin secretion.

Authors:  Haruto Katahira; Masataka Sunagawa; Daishi Watanabe; Yasuaki Kanada; Ayami Katayama; Risa Yamauchi; Masashi Takashima; Shintaro Ishikawa; Tadashi Hisamitsu
Journal:  Neuropsychiatr Dis Treat       Date:  2017-03-20       Impact factor: 2.570

Review 8.  A review of orexin's unprecedented potential as a novel, highly-specific treatment for various localized and metastatic cancers.

Authors:  Nicole L Graybill; Volkmar Weissig
Journal:  SAGE Open Med       Date:  2017-11-03

9.  Dual Orexin Receptor Antagonist Attenuates Increases in IOP, ICP, and Translaminar Pressure Difference After Stimulation of the Hypothalamus in Rats.

Authors:  Arthur A DeCarlo; Nathan Hammes; Philip L Johnson; Anantha Shekhar; Brian C Samuels
Journal:  Invest Ophthalmol Vis Sci       Date:  2022-03-02       Impact factor: 4.799

Review 10.  An overview of the orexinergic system in different animal species.

Authors:  Idris A Azeez; Olumayowa O Igado; James O Olopade
Journal:  Metab Brain Dis       Date:  2021-07-05       Impact factor: 3.584

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.